ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,915.04
      0.28%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG
      6. Genmab AS (GE9)

      7. Genmab AS (GE9) News

      GE9 Genmab AS

      260.80
      2.40 (0.93%)
      May 31 2024 - Closed
      Realtime Data
      Company Name Stock Ticker Symbol Market Type
      Genmab AS GE9 Tradegate Ordinary Share
        Price Change Change Percent Stock Price Last Traded
      2.40 0.93% 260.80 17:50:06
      Open Price Low Price High Price Close Price Prev Close
      258.90 258.20 261.00 260.80 258.40
      more quote information »

      Recent News

      Date Time Source Heading
      6/01/202410:00GLOBEInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in..
      5/27/202410:16GLOBETransactions in Connection with Share Buy-back Program
      5/23/202417:00GLOBEGenmab to Showcase Data in Various Patient Populations to be..
      5/21/202411:06GLOBEGenmab Completes Acquisition of ProfoundBio
      5/21/202407:19GLOBETransactions in Connection with Share Buy-back Program
      5/14/202410:02GLOBEGenmab to Present New and Updated Results From Multiple..
      5/13/202410:09GLOBETransactions in Connection with Share Buy-back Program
      5/07/202414:27GLOBECapital Increase in Genmab as a Result of Employee Warrant..
      5/06/202410:01GLOBETransactions in Connection with Share Buy-back Program
      5/02/202411:01GLOBEGenmab Announces Financial Results for the First Quarter of..
      4/29/202418:40GLOBETIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval..
      4/29/202404:24GLOBETransactions in Connection with Share Buy-back Program..
      4/22/202403:30GLOBETransactions in Connection with Share Buy-back Program..
      4/16/202406:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
      4/15/202404:07GLOBETransactions in Connection with Share Buy-back Program..
      4/08/202405:44GLOBETransactions in Connection with Share Buy-back Program
      4/03/202401:34GLOBEGenmab to Broaden and Strengthen Oncology Portfolio with..
      4/02/202403:24GLOBETransactions in Connection with Share Buy-back Program
      3/25/202409:30GLOBETransactions in Connection with Share Buy-back Program
      3/18/202405:49GLOBECompletion of share buy-back program
      3/15/202408:16GLOBEGenmab Announces Initiation of Share Buy-Back Program
      3/13/202416:58GLOBETransactions with shares and linked securities in Genmab A/S..
      3/13/202416:52GLOBEConstitution of the Board of Directors in Genmab A/S, Grant..
      3/13/202411:13GLOBEPassing of Genmab A/S’ Annual General Meeting
      3/11/202405:42GLOBETransactions in connection with share buy-back program
      3/04/202413:10GLOBETransactions with shares and linked securities in Genmab A/S..
      3/04/202404:29GLOBETransactions in connection with share buy-back program
      3/01/202418:04GLOBETransactions with shares and linked securities in Genmab A/S..
      2/29/202410:48GLOBETransactions with shares and linked securities in Genmab A/S..
      2/27/202415:42GLOBETransactions with shares and linked securities in Genmab A/S..
      2/27/202415:40GLOBECapital Increase in Genmab as a Result of Employee Warrant..
      2/26/202419:45GLOBEU.S. FDA Accepts for Priority Review the Supplemental..
      2/26/202405:21GLOBETransactions in connection with share buy-back program
      2/23/202417:50GLOBETransactions with shares and linked securities in Genmab A/S..
      2/23/202417:35GLOBEGrant of Restricted Stock Units to Management and Employees..
      2/19/202404:40GLOBETransactions in connection with share buy-back program
      2/15/202406:00GLOBENotice to Convene the Annual General Meeting of Genmab A/S
      2/14/202414:09GLOBEGenmab Files Annual Report with the U.S. Securities and..
      2/14/202411:41GLOBEGenmab Announces Initiation of Share Buy-Back Program
      2/14/202411:02GLOBEGenmab Publishes 2023 Annual Report
      2/02/202406:45GLOBETisotumab Vedotin Marketing Authorization Application..
      1/25/202414:22GLOBEGrant of Restricted Stock Units and Warrants to Employees in..
      1/23/202406:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
      1/22/202418:40GLOBEGenmab Announces Decision in Arbitration Appeal under..
      1/09/202406:45GLOBETIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics..
      1/03/202400:55GLOBETransactions With Shares and Linked Securities in Genmab A/S..
      1/02/202409:52GLOBEGenmab to Present at the 42nd Annual J.P. Morgan Healthcare..
      12/12/202307:00GLOBEGenmab to Hold 2023 R&D Update and ASH Data Review Meeting
      12/09/202312:00GLOBENew Pivotal Data for Bispecific Antibody Epcoritamab..
      12/05/202317:26GLOBECapital Increase in Genmab as a Result of Employee Warrant..

      Your Recent History

      TG
      GE9
      Genmab AS
      Delayed Upgrade Clock